ADULT ACUTE MYELOID LEUKEMIA WITH MATURATION
Clinical trials for ADULT ACUTE MYELOID LEUKEMIA WITH MATURATION explained in plain language.
Never miss a new study
Get alerted when new ADULT ACUTE MYELOID LEUKEMIA WITH MATURATION trials appear
Sign up with your email to follow new studies for ADULT ACUTE MYELOID LEUKEMIA WITH MATURATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for older leukemia patients
Disease control OngoingThis study tested a combination of two drugs, azacitidine and gemtuzumab ozogamicin, in 133 adults aged 60 and older with untreated acute myeloid leukemia (AML). The goal was to see if the combination could safely lead to complete remission (no signs of cancer) and improve surviv…
Matched conditions: ADULT ACUTE MYELOID LEUKEMIA WITH MATURATION
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New drug combo shows promise in Hard-to-Treat leukemia
Disease control OngoingThis study tests whether adding the drug decitabine to standard chemotherapy can help more people with acute myeloid leukemia (AML) achieve remission. About 178 adults with less favorable types of AML will receive either low or high dose decitabine alongside chemo. The goal is to…
Matched conditions: ADULT ACUTE MYELOID LEUKEMIA WITH MATURATION
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 13, 2026 16:02 UTC